Jupiter Neurosciences Inc (NASDAQ:JUNS) does about 1.05M shares in volume on a normal day but saw 2929163 shares change hands in the recent trading day. The company now has a market cap of 46.68M USD. Its current market price is $1.41, marking a decrease of -2.76% compared to the previous close of $1.45. The 52 week high reached by this stock is $19.51 whilst the lowest price level in 52 weeks is $1.16.
Jupiter Neurosciences Inc (JUNS) has a 20-day trading average at $7.4290 and the current price is -92.77% off the 52-week high compared with 21.55% distance from its 52-week low. If we look at the stock’s price movements over the week, volatility stands at 65.53%, which decreases to 28.83% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 31.13 to suggest the stock is neutral.
The consensus objective for the share price is $30.00, suggesting that the stock has a potential upside of 95.3% over the period.
The current price level is -81.02%, -83.27%, and -83.27% away from its SMA20, SMA50, and SMA200 respectively, with the JUNS price moving above the 50-day SMA on current market day. Jupiter Neurosciences Inc (JUNS) stock is down -66.98% over the week and -85.51% over the past month. Its price is -86.82% year-to-date.
The company’s next earnings report forecasts estimating quarterly EPS at -0.02 and -0.06 for whole year.
To reach the target analysts have set, the stock logically needs to grow 95.3 percent from here.
Outstanding shares total 33.10M with insiders holding 54.49% of the shares and institutional holders owning 0.00% of the company’s common stock.
